NCT03518099 (Survibio) is a NA clinical trial of blood sampling in Acute Mesenteric Ischemia, sponsored by Assistance Publique - Hôpitaux de Paris.

Who is sponsoring NCT03518099?

NCT03518099 is sponsored by Assistance Publique - Hôpitaux de Paris.

What drugs are being tested in NCT03518099?

Interventions in NCT03518099: blood sampling.

What condition does NCT03518099 study?

NCT03518099 studies Acute Mesenteric Ischemia.

Is NCT03518099 still recruiting?

NCT03518099 is currently recruiting now. Last updated 16 December 2025.

Last reviewed 2025-12-16 · How we verify

NCT03518099: Survibio

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Searching Biomarkers of Acute Intestinal Ischemic Injuries

Recruiting now NA Last updated 16 December 2025

What this trial tests

NA trial testing blood sampling in Acute Mesenteric Ischemia in 556 participants. Currently enrolling.

Timeline

16 November 2018

Primary endpoint
31 December 2027

30 July 2028

Quick facts

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	556
Start date	16 November 2018
Primary completion	31 December 2027
Estimated completion	30 July 2028
Sites	1 location across France

Drugs / interventions tested

blood sampling — full drug profile →

Conditions studied

Acute Mesenteric Ischemia — all drugs for Acute Mesenteric Ischemia →

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

18 and older, any sex, with Acute Mesenteric Ischemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the SURVIBIO study is to characterize accurate biomarkers for acute mesenteric ischemia, in particular at early stages. In the study, the development of biomarkers will be based on the analysis of human biological samples from patients and controls that will be conserved in a biological library. Samples will be analysed in the Laboratory for Vascular Translational Sciences (LVTS, Inserm U1148), in the Department of Biochemistry (Pr Puy, Dr Peoc'h), in Paris V university , in Imperial College of London (Pr Dumas), in Jacques Monod Institute and in Maastricht University Medical Center . The candidate markers will be determined according to an a priori method (form markers already described in the literature) and with no a priori strategy using -omics methods.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Diagnostic Performance of Clinical and Routine Laboratory Data in Acute Mesenteric Arterial Occlusion-An International Multicenter Study.
Soltanzadeh-Naderi Y, Reintam Blaser A, Björck M, Nuzzo A, et al · · 2024 · cited 5× · PMID 39682613 · DOI 10.3390/diagnostics14232705

Verify or expand the search:

Other trials of blood sampling

Trials testing the same drug.

NCT07467109 — A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of · not yet recruiting
NCT07347613 — Long-term Follow-up of Diabetic Patients From the GLUTADIAB Study · not yet recruiting
NCT07472387 — Impact of Androgen Signaling on the Composition of the Immune Microenvironment in Glioblastomas · NA · not yet recruiting
NCT07477769 — Lymphocyte Phenotype of Autosomal Recessive Congenital Ichthyoses Mutated NIPAL4 (Nipal4-nEDD) · not yet recruiting
NCT07236177 — B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosi · EARLY_PHASE1 · recruiting

Other recruiting trials for Acute Mesenteric Ischemia

Currently open trials in the same condition.

NCT06869564 — Evaluation of the Discriminative Abilities of Biomarkers for the Diagnosis of Acute Mesenteric Ischemia Compared With An · NA · recruiting
NCT06387147 — ORal Antibiotics in Acute Mesenteric Ischemia · Phase 3 · recruiting
NCT06445660 — The Feasibility of a Radiological Score Based on CT Signs for Recognizing Salvageable Bowel in Acute Mesenteric Ischemia · recruiting

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03518099 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
Last refreshed: 16 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03518099.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing